Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Bruker Corporation ( BRKR ) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 10:45 AM EDT

I think we're in that inflection point where people are trying to understand biology much more deeply. Disease biology, drug discovery, biomarkers that may play a role in diagnostics or MRD or whatever it may be. And the biological questions, I think, more so than the technological questions, what magnet, what laser, what mirror, what mass spec do I need? There's fast evolution there as well, but I think we're at that inflection point where people talk to -- call it sometimes biology or disease biology 2.0. We've used or coined the term the post-genomic era of drug discovery and disease biology. I think that's where the